SCHEDULE 13G/A

Arcutis Biotherapeutics Inc

Common Stock, par value $0.0001 · CUSIP: 03969K108

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• Polar Capital Holdings Plc

  Shares: 6,706,475.00 · Class: 5.65%

• Polar Capital LLP

  Shares: 6,706,475.00 · Class: 5.65%

• Polar Capital Funds PLC - Biotechnology Fund

  Shares: 6,000,000.00 · Class: 5.06%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.